First Rounders

First Rounder: Colin Goddard


Listen Later

Colin Goddard is former CEO of OSI Pharmaceuticals, and current chairman and CEO of Coferon. His conversation with Nature Biotechnology details the history behind OSI's blockbuster drug Tarceva (erlotinib), the benefits of having a British accent in the United States and how to survive a hostile takeover.

Hosted on Acast. See acast.com/privacy for more information.

...more
View all episodesView all episodes
Download on the App Store

First RoundersBy Nature Biotechnology

  • 4.4
  • 4.4
  • 4.4
  • 4.4
  • 4.4

4.4

63 ratings


More shows like First Rounders

View all
Planet Money by NPR

Planet Money

30,718 Listeners

Pod Save America by Crooked Media

Pod Save America

86,587 Listeners

The Daily by The New York Times

The Daily

110,845 Listeners

Up First from NPR by NPR

Up First from NPR

55,986 Listeners